K'Lene LeCompte

Chief Business Officer at Thynk Capital

K'Lene LeCompte has a wealth of experience in the healthcare industry. Starting in 2000, they were the Executive Office Manager at AMN Healthcare, where they provided round the clock support to the CEO and Executive Staff and assisted with the transition of the company from private to public. In 2004, they became the Executive Vice President of Francis Enterprises, where they were responsible for directing and managing the overall operational, administrative, and financial performance of the company. In 2008, they moved to Pathway Genomics as the Chief Business Officer, where they were a key player in building the company from inception to its current status as a multi-million dollar, pre-IPO corporation and global leader in genetic research & testing. In 2016, they became a Board Member for the March of Dimes, where they helped raise awareness of the 15 Million babies born prematurely each year around the world and the 1 Million that will die. From 2017 to 2021, they worked at Klotho Therapeutics, Inc. as the Chief Business Officer, Thynk Capital, LLC. as the Chief Business Officer, and IMX Health, LLC. as the Chief Administrative Officer.

K'Lene LeCompte obtained a Bachelor of Science in Business Administration, Management and Operations from Fowler College of Business at San Diego State University. K'Lene also holds a Business Management Certificate from UC San Diego, obtained in March 2013, and a Hotel Management Certificate from Washington State University, obtained in 1998.

Links

Previous companies

AMN Healthcare logo

Peers

View in org chart

Timeline

  • Chief Business Officer

    December, 2017 - present